Moderna Bests Pfizer in Study of Five COVID-19 Vaccines

The Moderna Inc. and Russian Sputnik V COVID-19 vaccines topped a large-scale study of five different shots, edging the version from Pfizer Inc. and BioTech SE in effectiveness. A study by Hungarian researchers published by the Clinical Microbiology and Infection …

Read more

Putin Confirms Taking COVID-19 Nasal Vaccine

Russian President Vladimir Putin confirmed he had taken an experimental nasal vaccine against the coronavirus on Wednesday, three days after his booster shot. “That was all—I didn’t feel anything. Nothing. Today, after these two procedures, I already did some sport …

Read more

FDA Approves Pfizer and Moderna Vaccine Booster Shots Under Emergency Use Authorization for US Adults

The US Food and Drug Administration (FDA) has expanded the emergency use authorization for the Pfizer and Moderna COVID-19 vaccine boosters for adults. The FDA approval came after the Biden planned to start distributing boosters to all adults starting Sept. …

Read more

European Commission Signs COVID-19 Vaccine Deal with Valneva

The European Commission has approved on Nov. 10 a deal with French vaccine company Valneva to supply up to 60 million doses of its COVID-19 vaccine candidate over the next two years. Under the deal, nearly 27 million doses of …

Read more

WHO Warns of Vaccine Syringe Shortages

The World Health Organization (WHO) warned that there could be a shortage of 1 to 2 billion syringes for COVID-19 vaccines that could undermine immunization efforts. The UN health agency called to medical manufacturers on Nov. 9 to ramp up …

Read more

Canada Authorizes Pfizer COVID-19 Booster Shot for Adults

Canada has authorized on Nov. 9 a booster dose of the Pfizer-BioNTech COVID-19 for adults aged 18 and older. The booster shot is identical to the regular Pfizer-BioNTech COVID-19 and should be taken at least six months after the primary …

Read more

WHO Approves India’s Covaxin for Emergency Use

The World Health Organization (WHO) has granted approval for emergency use to India’s homegrown COVID-19 vaccine Covaxin on Nov. 3. Developed by Bharat Biotech, Covaxin becomes the eight COVID-19 vaccine to be added to WHO’s emergency use listing. The approval …

Read more

Novavax Files for COVID-19 Vaccine Authorization in UK

Novavax has submitted an authorization filing for its COVID-19 vaccine in the United Kingdom, the biotechnology company announced on Oct. 27. Novavax said that it has completed its rolling regulatory submission to the UK Medicines and Healthcare products Regulatory Agency, …

Read more

European Medicines Agency Approves Moderna COVID-19 Booster Shot

The drugs regulator of the European Union (EU) approved on Oct. 25 the COVID-19 booster shot developed by Moderna. The European Medicines Agency (EMA) said that the Moderna COVID-19 booster dose “may be considered” in people aged 18 years and …

Read more

CDC Vaccine Advisers Vote to Recommend Moderna, Johnson & Johnson COVID-19 Booster Shots

An independent panel of vaccine advisers to the United States Centers for Disease Control and Prevention (CDC) voted unanimously on Oct. 21 to recommend booster shots of the Moderna and Johnson & Johnson COVID-19 vaccines. The recommendations from the Advisory …

Read more